持田製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4534/E00947 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2021/12/30 | 日証協 | 169,280株 | 0% | 115,718株 | 0% | 119,049株 | 0% | 75,102株 | 0% |
2021/12/24 | 日証協 | 169,280株 | +14.95% | 115,718株 | +0.83% | 119,049株 | +45.85% | 75,102株 | +281.95% |
2021/12/17 | 日証協 | 147,270株 | +14.37% | 114,763株 | +147.53% | 81,627株 | -10.72% | 19,663株 | -40.11% |
2021/12/10 | 日証協 | 128,770株 | +17.56% | 46,363株 | -5.01% | 91,427株 | +47.64% | 32,832株 | +107.73% |
2021/12/03 | 日証協 | 109,539株 | +13.26% | 48,807株 | +38.11% | 61,927株 | +8.6% | 15,805株 | +269.19% |
2021/11/26 | 日証協 | 96,712株 | -11.42% | 35,340株 | -27.45% | 57,022株 | -14.28% | 4,281株 | -73.7% |
2021/11/19 | 日証協 | 109,181株 | +18.85% | 48,711株 | -15.36% | 66,521株 | +10.46% | 16,280株 | +8.51% |
2021/11/05 | 日証協 | 59,994株 | -37.49% | 8,165株 | -90.17% | 56,421株 | -40.36% | 3,500株 | -93.92% |
2021/10/29 | 日証協 | 95,974株 | +8.08% | 83,103株 | +186.93% | 94,598株 | +5.31% | 57,550株 | +48.78% |
2021/10/22 | 日証協 | 88,800株 | -0.4% | 28,963株 | +27.59% | 89,827株 | -9.81% | 38,680株 | +69.06% |
2021/10/15 | 日証協 | 89,153株 | +9.55% | 22,700株 | -23.44% | 99,600株 | -6.37% | 22,880株 | -77.44% |
2021/10/08 | 日証協 | 81,383株 | -30.28% | 29,650株 | -51.94% | 106,380株 | -32.07% | 101,440株 | +76.89% |
2021/10/01 | 日証協 | 116,733株 | -49.77% | 61,700株 | -76.78% | 156,600株 | -32.9% | 57,346株 | -45.74% |
2021/09/24 | 日証協 | 232,381株 | +8.56% | 265,736株 | -58.93% | 233,400株 | +6.43% | 105,679株 | +31.82% |
2021/09/17 | 日証協 | 214,063株 | +7.7% | 647,090株 | +138.12% | 219,301株 | +3.79% | 80,170株 | +145.94% |
2021/09/10 | 日証協 | 198,763株 | -18.01% | 271,746株 | -14.27% | 211,301株 | -18.81% | 32,597株 | -35.42% |
2021/09/03 | 日証協 | 242,414株 | +7.07% | 316,966株 | +48.07% | 260,251株 | -4.24% | 50,476株 | -29.51% |
2021/08/27 | 日証協 | 226,409株 | -1.96% | 214,066株 | +119.55% | 271,785株 | +13.9% | 71,610株 | +180.82% |
2021/08/20 | 日証協 | 230,938株 | -2.96% | 97,504株 | -3.39% | 238,614株 | -1.12% | 25,500株 | -22.02% |
※株式分割は考慮していませんのでご注意ください。
Page Top